Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
For patients with sickle cell disease (SCD), the transition from pediatric to adult care is a high-risk period that is often marked by gaps in care and worsening outcomes. This educational program brings together experienced hematologists to share data, clinical insights, and practical strategies for supporting adolescents and young adults through this critical phase. Faculty will discuss best practices for transition planning, common barriers to successful handoffs, and approaches to improving continuity of care and patient engagement. Through expert commentary and real-world examples, participants will gain actionable guidance to strengthen transition processes and improve long-term outcomes in SCD.
Target Audience
This educational activity is primarily directed toward hematologists, nurse practitioners, and physician assistants. Other clinicians involved in the care of SCD will also be invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
Apply strategies to optimize the transition from pediatric to adult care for patients with SCD
Biree Andemariam, MD
Professor of Medicine
Director, New England Sickle Cell Institute
Director, Connecticut Bleeding Disorders Center
University of Connecticut Health
Farmington, CT
Advisor, Consultant, Speaker, Honoraria Recipient: Afimmune, Agios, Beam Therapeutics, bluebird bio, Bristol Myers Squibb, Chiesi, Editas, Fulcrum, Hemanext, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Vertex; Grant/Research Funding: Afimmune, Agios, Hemanext, Novo Nordisk, Pfizer
Nirmish Shah, MD
Duke University
Durham, NC
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.